Cargando…

The effectiveness gap in COPD: a mixed methods international comparative study

BACKGROUND: There has been a large increase in treatment and in research on chronic obstructive pulmonary disease (COPD) from the common starting point of the original Global Initiative for Chronic Obstructive Lung Disease (GOLD) study. There is currently little evidence on the degree of similarity...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosanquet, Nick, Dean, Lucy, Iordachescu, Irina, Sheehy, Colm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442783/
https://www.ncbi.nlm.nih.gov/pubmed/23549383
http://dx.doi.org/10.4104/pcrj.2013.00035
_version_ 1783407757226934272
author Bosanquet, Nick
Dean, Lucy
Iordachescu, Irina
Sheehy, Colm
author_facet Bosanquet, Nick
Dean, Lucy
Iordachescu, Irina
Sheehy, Colm
author_sort Bosanquet, Nick
collection PubMed
description BACKGROUND: There has been a large increase in treatment and in research on chronic obstructive pulmonary disease (COPD) from the common starting point of the original Global Initiative for Chronic Obstructive Lung Disease (GOLD) study. There is currently little evidence on the degree of similarity and difference between national programmes or on the linkage between research and policy. AIMS: To review the evidence on programme development and the effectiveness gap from the UK, France, Germany, and Finland. METHODS: Visits and literature reviews were undertaken for regional centres in Lancashire, Nord-Pas de Calais, and Finland, Eurostat data on mortality and hospital discharges were analysed, and telephone interviews were conducted in Nord-Rhein Westphalia. RESULTS: There have been very significant differences in programme development from the original GOLD starting point. The UK has national strategies but they are without consistent local delivery. The French Affection de Longue Durée (ALD) programme limits special help to at most 10% of patients and there is little use of spirometry in primary care. Germany has a more general Disease Management Programme with COPD as a late starter. Finland has had a successful 10-year programme. The results for the effectiveness gap on hospital discharges show a major difference between Finland (40.7% fall in discharges) and others (increases of 6.0–43.7%). CONCLUSIONS: The results show the need for a simpler programme in primary care to close the effectiveness gap. Such a programme is outlined based on preventing the downward spiral for high-risk patients.
format Online
Article
Text
id pubmed-6442783
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-64427832019-07-01 The effectiveness gap in COPD: a mixed methods international comparative study Bosanquet, Nick Dean, Lucy Iordachescu, Irina Sheehy, Colm Prim Care Respir J Research Paper BACKGROUND: There has been a large increase in treatment and in research on chronic obstructive pulmonary disease (COPD) from the common starting point of the original Global Initiative for Chronic Obstructive Lung Disease (GOLD) study. There is currently little evidence on the degree of similarity and difference between national programmes or on the linkage between research and policy. AIMS: To review the evidence on programme development and the effectiveness gap from the UK, France, Germany, and Finland. METHODS: Visits and literature reviews were undertaken for regional centres in Lancashire, Nord-Pas de Calais, and Finland, Eurostat data on mortality and hospital discharges were analysed, and telephone interviews were conducted in Nord-Rhein Westphalia. RESULTS: There have been very significant differences in programme development from the original GOLD starting point. The UK has national strategies but they are without consistent local delivery. The French Affection de Longue Durée (ALD) programme limits special help to at most 10% of patients and there is little use of spirometry in primary care. Germany has a more general Disease Management Programme with COPD as a late starter. Finland has had a successful 10-year programme. The results for the effectiveness gap on hospital discharges show a major difference between Finland (40.7% fall in discharges) and others (increases of 6.0–43.7%). CONCLUSIONS: The results show the need for a simpler programme in primary care to close the effectiveness gap. Such a programme is outlined based on preventing the downward spiral for high-risk patients. Nature Publishing Group 2013-06 2013-04-02 /pmc/articles/PMC6442783/ /pubmed/23549383 http://dx.doi.org/10.4104/pcrj.2013.00035 Text en Copyright © 2013 Primary Care Respiratory Society UK
spellingShingle Research Paper
Bosanquet, Nick
Dean, Lucy
Iordachescu, Irina
Sheehy, Colm
The effectiveness gap in COPD: a mixed methods international comparative study
title The effectiveness gap in COPD: a mixed methods international comparative study
title_full The effectiveness gap in COPD: a mixed methods international comparative study
title_fullStr The effectiveness gap in COPD: a mixed methods international comparative study
title_full_unstemmed The effectiveness gap in COPD: a mixed methods international comparative study
title_short The effectiveness gap in COPD: a mixed methods international comparative study
title_sort effectiveness gap in copd: a mixed methods international comparative study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442783/
https://www.ncbi.nlm.nih.gov/pubmed/23549383
http://dx.doi.org/10.4104/pcrj.2013.00035
work_keys_str_mv AT bosanquetnick theeffectivenessgapincopdamixedmethodsinternationalcomparativestudy
AT deanlucy theeffectivenessgapincopdamixedmethodsinternationalcomparativestudy
AT iordachescuirina theeffectivenessgapincopdamixedmethodsinternationalcomparativestudy
AT sheehycolm theeffectivenessgapincopdamixedmethodsinternationalcomparativestudy
AT bosanquetnick effectivenessgapincopdamixedmethodsinternationalcomparativestudy
AT deanlucy effectivenessgapincopdamixedmethodsinternationalcomparativestudy
AT iordachescuirina effectivenessgapincopdamixedmethodsinternationalcomparativestudy
AT sheehycolm effectivenessgapincopdamixedmethodsinternationalcomparativestudy